In the heart of Florida, a battle against Alzheimer’s disease is being waged with unprecedented vigor. Earlier this year, a significant stride was made with the unanimous passage of the Alzheimer’s Disease Awareness Initiative in the Florida legislature. This initiative, spearheaded by Rep. Dean Black, is rooted in a fundamental principle: a robust system is only as effective as the awareness of those who need it.
The personal stakes of this fight are profound. Rep. Black’s own experience with losing his father to Alzheimer’s underscores the urgency and the emotional toll of this disease. Alzheimer’s doesn’t just affect the individual; it reshapes families, demanding a comprehensive and compassionate response.
The Florida Model: A Decade of Progress
Florida has been at the forefront of Alzheimer’s care for over four decades, establishing a network that includes respite care in all 67 counties, Memory Disorder Clinics, the Florida Brain Bank, and the Ed and Ethel Moore Alzheimer’s Research Program. These resources support nearly 580,000 households across the state—more than the entire population of Miami.
In 2026, Florida took another leap forward with the expansion of Alzheimer’s training and education standards. This move ensures that both professional caregivers and family members are better equipped to handle the challenges of this disease. The goal is clear: to empower caregivers with the knowledge and tools they need to provide dignified and effective care.
The Power of Prevention and Early Detection
The Trump administration‘s focus on chronic disease prevention through the Make America Healthy Again (MAHA) movement has highlighted the importance of lifestyle choices in reducing dementia risk. Research increasingly supports the idea that priorities championed by MAHA—such as better food choices, adequate sleep, regular exercise, and metabolic health—can significantly lower the risk of Alzheimer’s.
Advancements in early detection and treatment are also game-changers. New blood tests can identify Alzheimer’s before symptoms appear, and innovative therapies can slow the disease’s progression in its earliest stages. These breakthroughs are not theoretical; they are being implemented in clinics and labs across the country.
The National Imperative
The urgency to address Alzheimer’s on a national scale cannot be overstated. With over 7 million Americans currently living with the disease and projections indicating this number will nearly double by 2060, the need for a coordinated federal response is critical. Alzheimer’s is one of the few leading causes of death in the U.S. without a cure, costing the healthcare system an estimated $781 billion annually.
A serious federal initiative would harness American innovation, prioritize prevention, ensure timely diagnosis, and guarantee access to approved treatments. The public is already on board, with over 90% of voters supporting measures like Medicare coverage for early-detection blood tests and easier access to Alzheimer’s therapies. This is not a partisan issue; it is a consensus that can drive meaningful change.
Leading the Way
The alignment of science, public will, and presidential leadership presents a rare opportunity to make significant strides in the fight against Alzheimer’s. President Donald trump and his administration have already laid the groundwork with the MAHA initiative. With this administration leading the charge, America can finally turn the tide against this devastating disease.
Florida’s experience demonstrates what is possible with a comprehensive, well-funded approach to Alzheimer’s care. By building on this model and scaling it nationally, we can provide hope and support to the millions of families affected by this disease. The time to act is now.
